logo
Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor
Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature
Benefits versus risks of pharmacological prophylaxis to prevent symptomatic venous thromboembolism in unselected medical patients revisited. Meta-analysis of the medical literature
Pre PCI hospital antithrombotic therapy for ST elevation myocardial infarction: striving for consensus
To bridge or not to bridge: these are the questions
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program
Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction
ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis
Urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin-F1α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg
Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention
Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo
High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients
Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase
Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels
Right hepatic artery thrombosis in an essential polycythemia vera patient following pancreato-biliary surgery for severe pancreatitis
Highlights of the seventh annual platelet colloquium
Biomarker science: on a theme of personalized medicine
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil